CANDLe syndrome as a paradigm of proteasome-related autoinflammation

Frontiers in Immunology

Volumn 8, Issue AUG, 2017, Pages

  Torrelo, Antonio ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Autoinflammation; CANDLE; Immunoproteasome; Interferonopathy; Neutrophilic dermatosis; Proteasome

Indexed keywords

BARICITINIB; INTERFERON; JANUS KINASE 1; JANUS KINASE 2; PROTEASOME; PROTEIN KINASE TYK2; STAT1 PROTEIN; STAT2 PROTEIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; CELL STRESS; CLINICAL FEATURE; FEVER; GENE; GENE MUTATION; HUMAN; LIPODYSTROPHY; PROTEASOME SUBUNIT BETA TYPE 4 GENE; REVIEW; SKIN DEFECT; WASTING SYNDROME; WEIGHT REDUCTION;

EID: 85027413472     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00927     Document Type: Review

References (43)

1. Torrelo A, Patel S, Colmenero I, Gurbindo D, Lendínez F, Hernández A, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol (2010) 62:489-95. doi:10.1016/j.jaad.2009.04.046
2. Liu Y, Ramot Y, Torrelo A, Paller AS, Si N, Babay S, et al. Mutations in proteasome subunit ß type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum (2012) 64:895-907. doi:10.1002/art.33368
3. Tüfekçi O, Bengoa S, Karapinar TH, Ataseven EB, Irken G, Oren H. CANDLE syndrome: a recently described autoinflammatory syndrome. J Pediatr Hematol Oncol (2015) 37:296-9. doi:10.1097/MPH.0000000000000212
4. Garg A, Hernandez MD, Sousa AB, Subramanyam L, Martínez de Villarreal L, dos Santos HG, et al. An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. J Clin Endocrinol Metab (2010) 95:58-63. doi:10.1210/jc. 2010-0488
5. Kanazawa N. Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy. Allergol Int (2012) 61:197-206. doi:10.2332/allergolint.11-RAI-0416
6. Agarwal AK, Xing C, DeMartino GN, Mizrachi D, Hernandez MD, Sousa AB, et al. PSMB8 encoding the ß5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet (2010) 87:866-72. doi:10.1016/j. ajhg.2010.10.031
7. Arima K, Kinoshita A, Mishima H, Kanazawa N, Kaneko T, Mizushima T, et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome. Proc Natl Acad Sci U S A (2011) 108:14914-9. doi:10.1073/pnas.1106015108
8. Kitamura A, Maekawa Y, Uehara H, Izumi K, Kawachi I, Nishizawa M, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest (2012) 121:4150-60. doi:10.1172/JCI58414
9. Brehm A, Liu Y, Sheikh A, Marrero B, Omoyinmi E, Zhou Q, et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J Clin Invest (2015) 125:4196-211. doi:10.1172/JCI81260
10. Mégarbané A, Sanders A, Chouery E, Delague V, Medlej-Hashim M, Torbey PH. An unknown autoinflammatory syndrome associated with short stature and dysmorphic features in a young boy. J Rheumatol (2002) 29: 1084-7.
11. McDermott A, Jacks J, Kessler M, Emanuel PD, Gao L. Proteasome-associated autoinflammatory syndromes: advances in pathogenesis, clinical presentations, diagnosis, and management. Int J Dermatol (2015) 54:121-9. doi:10.1111/ijd.12695
12. Touitou I, Galeotti C, Rossi-Semerano L, Hentgen V, Piram M, Koné-Paut I, et al. The expanding spectrum of rare monogenic autoinflammatory diseases. Orphanet J Rare Dis (2013) 8:162. doi:10.1186/1750-1172-8-162
13. Xirotagaros G, Hernández-Ostiz S, Arostegui JI, Torrelo A. Newly described autoinflammatory diseases in pediatric dermatology. Pediatr Dermatol (2016) 33:602-14. doi:10.1111/pde.12984
14. Gomes AV. Genetics of proteasome diseases. Scientifica (Cairo) (2013) 2013:637629. doi:10.1155/2013/637629
15. Fricke B, Heink S, Steffen J, Kloetzel PM, Kruger E. The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep (2007) 8:1170-5. doi:10.1038/sj.embor.7401091
16. Heink S, Ludwig D, Kloetzel PM, Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A (2005) 102:9241-6. doi:10.1073/pnas.0501711102
17. Ebstein F, Kloetzel PM, Kruger E, Seifert U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci (2012) 69:2543-58. doi:10.1007/s00018-012-0938-0
18. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem (1994) 115:257-69. doi:10.1093/oxfordjournals.jbchem.a124327
19. Brown MG, Driscoll J, Monaco JJ. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature (1991) 353:355-7. doi:10.1038/353355a0
20. Kluk J, Rustin M, Brogan PA, Omoyinmi E, Rowczenio DM, Willcocks LC, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a report of a novel mutation and review of the literature. Br J Dermatol (2014) 170:215-7. doi:10.1111/bjd.12600
21. Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct effects of type I interferons on cells of the immune system. Clin Cancer Res (2011) 17:2619-27. doi:10.1158/1078-0432.CCR-10-1114
22. Krüger E, Kloetzel PM. Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol (2012) 24:77-83. doi:10.1016/j.coi.2012.01.005
23. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell (2010) 142:613-24. doi:10.1016/j.cell.2010. 07.036
24. Rice GI, Melki I, Frémond ML, Briggs TA, Rodero MP, Kitabayashi N, et al. Assessment of type I interferon signaling in pediatric inflammatory disease. J Clin Immunol (2017) 37:123-32. doi:10.1007/s10875-016-0359-1
25. Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med (2016) 213:2527-38. doi:10.1084/jem.20161596
26. Torrelo A, Colmenero I, Requena L, Paller AS, Ramot Y, Richard Lee CC, et al. Histologic and immunohistochemical features of the skin lesions in CANDLE syndrome. Am J Dermatopathol (2015) 37:517-22. doi:10.1097/DAD.0000000000000340
27. Crow YJ. Type I interferonopathies: Mendelian type I interferon up-regulation. Curr Opin Immunol (2015) 32:7-12. doi:10.1016/j.coi.2014.10.005
28. Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol (2009) 16:392-404. doi:10.1097/PAP.0b013e3181bb6bc2
29. Ramos PC, Marques AJ, London MK, Dohmen RJ. Role of C-terminal extensions of subunits ß2 and ß7 in assembly and activity of eukaryotic proteasomes. J Biol Chem (2004) 279:14323-30. doi:10.1074/jbc. M308757200
30. Ramot Y, Czarnowicki T, Maly A, Navon-Elkan P, Zlotogorski A. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a case report. Pediatr Dermatol (2011) 28:538-41. doi:10.1111/j.1525-1470.2010.01163.x
31. Cavalcante MP, Brunelli JB, Miranda CC, Novak GV, Malle L, Aikawa NE, et al. CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutation. Eur J Pediatr (2016) 175:735-40. doi:10.1007/s00431-015-2668-4
32. Wang H, Das L, Tan Hung Tiong J, Vasanwala RF, Arkachaisri T. CANDLE syndrome: an extended clinical spectrum. Rheumatology (Oxford) (2014) 53:2119-20. doi:10.1093/rheumatology/keu298
33. Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, et al. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) (2008) 87:70-86. doi:10.1097/MD.0b013e31816bc604
34. Torrelo A, España A, Boixeda P, Ledo A. Partial lipodystrophy and dermatomyositis. Arch Dermatol (1991) 127:1846-7. doi:10.1001/archderm. 1991.04520010088019
35. Brown TT. Approach to the human immunodeficiency virus-infected patient with lipodystrophy. J Clin Endocrinol Metab (2008) 93:2937-45. doi:10.1210/jc.2008-1019
36. Mallewa JE, Wilkins E, Vilar J, Mallewa M, Doran D, Back D, et al. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. J Antimicrob Chemother (2008) 62:648-60. doi:10.1093/jac/dkn251
37. Torrelo A, Noguera-Morel L, Hernández-Martín A, Clemente D, Barja JM, Buzón L, et al. Recurrent lipoatrophic panniculitis of children. J Eur Acad Dermatol Venereol (2017) 31:536-43. doi:10.1111/jdv.13858
38. Weise G, Hupp M, Kerstan A, Buttmann M. Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis. J Clin Neurosci (2012) 19:1312-3. doi:10.1016/j. jocn.2011.11.026
39. Ball NJ, Cowan BJ, Hashimoto SA. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases. J Cutan Pathol (2009) 36:331-7. doi:10.1111/j.1600-0560.2008.01019.x
40. Dávila-Seijo P, Hernández-Martín A, Torrelo A. Autoinflammatory syndromes for the dermatologist. Clin Dermatol (2014) 32:488-501. doi:10.1016/j. clindermatol.2014.02.004
41. Shwin KW, Lee CR, Goldbach-Mansky R. Dermatologic manifestations of monogenic autoinflammatory diseases. Dermatol Clin (2017) 35:21-38. doi:10.1016/j.det.2016.07.005
42. Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai WL, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A (2016) 113:10127-32. doi:10.1073/pnas.1612594113
43. Reinhardt A, Brogan P, Berkun Y, Brown D, Chira P, Gao L, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperatures (CANDLE): clinical characterization and initial response to Janus kinase inhibition with baricitinib. ACR/ARPH Annual Meeting; Oct 25-30; San Diego (2013).